Stay updated with breaking news from Mannkind Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of MannKind Co. (NASDAQ:MNKD – Get Free Report) shot up 3.8% during mid-day trading on Thursday . The company traded as high as $4.91 and last traded at $4.91. 937,343 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 2,684,604 shares. The stock had previously closed at […]
MannKind (NASDAQ:MNKD – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, May 8th. Analysts expect MannKind to post earnings of $0.02 per share for the quarter. MannKind (NASDAQ:MNKD – Get Free Report) last announced its earnings results on Tuesday, February 27th. The biopharmaceutical company reported $0.01 EPS […]
MannKind Co. (NASDAQ:MNKD – Free Report) – Analysts at Wedbush issued their Q2 2024 earnings estimates for shares of MannKind in a research report issued to clients and investors on Wednesday, February 28th. Wedbush analyst A. Argyrides forecasts that the biopharmaceutical company will post earnings of $0.02 per share for the quarter. Wedbush currently has […]
MannKind Co. (NASDAQ:MNKD – Free Report) – Analysts at Leerink Partnrs decreased their Q3 2024 EPS estimates for shares of MannKind in a research note issued to investors on Wednesday, February 28th. Leerink Partnrs analyst T. Smith now anticipates that the biopharmaceutical company will post earnings per share of $0.02 for the quarter, down from […]
MannKind Co. (NASDAQ:MNKD – Get Free Report) shares rose 10.6% during trading on Wednesday . The company traded as high as $4.26 and last traded at $4.18. Approximately 1,060,401 shares traded hands during trading, a decline of 56% from the average daily volume of 2,431,067 shares. The stock had previously closed at $3.78. Wall Street […]